21279 ā
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient; Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
Compositions, Methods, and Applications of a Synthetic Surfactant
#302COMPOSITION FOR PREVENTING OR TREATING ISCHEMIC DISEASES, COMPRISING CARDIAC STEM CELLS
#303FIBRE MIXTURE FOR YOUNG CHILDREN
#304MICRONEEDLE ARRAY WITH ACTIVE INGREDIENT
#305IMPROVED PATCH
#306Targeted Nanomedicine for Treating Vascular Disorders
#307FOAMED, RESILIENT, PROTEIN-BASED PRODUCT
#308Medicine Containing USAG-1-Targeting RNA Molecule for Tooth Regeneration Therapy
#309POLY (AMINO ACID) RHEOLOGY MODIFIER COMPOSITIONS AND METHODS OF USE
#310LINKED AND OTHER pH-TRIGGERED COMPOUNDS
#311FORMULATIONS OF CABAZITAXEL
#312COMPOSITION COMPRISING BACTERIUM OF THE GENUS ACIDIPROPIONIBACTERIUM OR PROCESSED PRODUCT THEREOF
#313Compositions and methods for dental mineralization
#314METHODS AND COMPOSITIONS FOR NUCLEIC ACID AND PROTEIN PAYLOAD DELIVERY
#315Anti-Interleukin-4 Receptor (IL-4R) Antibody Formulations
#316ALLERGEN PREPARATION
#317METHODS OF TREATING CUTANEOUS LUPUS ERYTHEMATOSUS AND SYSTEMIC LUPUS ERYTHEMATOSUS
#318SURFACTANT FORMULATIONS FOR INHALATION
#319METHODS OF INCREASING HEIGHT AND PROMOTING LINEAR BONE GROWTH
#320PROTEIN-BOUND CANNABINOID FORMULATIONS AND USES THEREOF
#321METHODS OF TREATING AUTOIMMUNE OR INFLAMMATORY CONDITIONS WITH CANNABIDIOL OR ITS DERIVATIVES/ANALOGS
#322CANNABINOIDS IN THE TREATMENT OF AUTISM SPECTRUM DISORDER
#323RAPIDLY INFUSING COMPOSITIONS FOR ORAL MUCOSAL DELIVERY AND METHODS
#324PACKAGING FOR RAPIDLY INFUSING COMPOSITION
#325RAPIDLY INFUSING COMPOSITIONS WITH SUPPLEMENTS AND TREATMENT METHODS
#326FOAM VACCINATION OF AVIANS
#327CO-AMORPHOUS FORM OF A SUBSTANCE AND A PROTEIN
#328COMPOSITIONS OF ENGINEERED EXOSOMES AND METHODS OF LOADING LUMINAL EXOSOMES PAY-LOADS
#329A PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING LUNG INJURY, A PREPARATION METHOD THEREFOR AND A USE THEREOF
#330USE OF CANNABINOIDS IN THE TREATMENT OF TOURETTE SYNDROME AND TIC DISORDERS
#331IMPROVED USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#332IMPROVED USE OF CANNABINOIDS IN THE TREATMENT OF ALZHEIMER'S DISEASE
#333PED5 INHIBITOR SEMI-SOLID COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF
#334ANTIHISTAMINE SEMI-SOLID CHEWABLE GEL COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF
#335USE OF SURFACTANT WITH HIGH MOLECULAR WEIGHT FISH GELATIN BASED DOSAGE FORMULATIONS TO IMPROVE FLOW CHARACTERISTICS
#336ENZYMATICALLY CROSSLINKED COMPOSITIONS
#337Method for bowel preparation
#338Compositions for Enhancing Bioavailability of Pharmaceuticals, Supplements and Ingested Substances
#339COMBINATION THERAPY OF MDNA55 AND A VASCULAR ENDOTHELIAL GROWTH FACTOR A (VEGF-A)
#340COMPOSITIONS, METHODS OF TREATMENT, AND CONTAINERS INCLUDING COMPOSITIONS
#341Intradermal Delivery of Extracellular Vesicle-Encapsulated Curcumin Using Dissolvable Microneedle Arrays
#342INTRINSICALLY-DISORDERED PROTEINS AS EMULSIFIERS
#343RAPIDLY DISINTERGRATING COMPOSTIONS AND METHODS (Nicotine)
#344COMPOSITIONS, METHODS, AND APPLICATIONS OF A SYNTHETIC SURFACTANT
#345Cis-platinum cross-linked protein hydrogel and preparation method thereof
#346PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME
#347FLOATING DRUG DELIVERY SYSTEMS COMPRISING CANNABINOIDS
#348SOLID DOSE PHARMACEUTICAL COMPOSITION
#349FORMULATIONS AND METHODS RELATED TO EYE IRRITATION AND RELATED
#350SOFT ORAL PRODUCT
#351VISCOSITY-REDUCING EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#352COMPOSITION COMPRISING AT LEAST ONE LABDANE DITERPENE AND METHOD FOR MANUFACTURING SAME
#353METALLO-LIOTHYRONINE
#354GEL BASE COMPOSITION FOR COMPOUNDING INTO A MUCOADHESIVE DELIVERY SYSTEM
#355METHODS FOR TREATING WOUNDS
#356Plasma-Treated Hydrogel Compositions and Uses Thereof
#357USE OF CANNABINOIDS IN THE TREATMENT OF COVID-19
#358Compositions and methods for treating epilepsy, seizures and other conditions
#359Pharmaceutical Composition Containing Elemene, Preparation Method Therefor, And Use Thereof
#360Compositions and methods for inhibiting the activity of LAR family phosphatases
#361SWEETENERS
#362NOVEL PEPTIDE, COMPOSITIONS AND METHOD FOR DELIVERY OF AGENTS INTO CELLS AND TISSUES
#363A SYSTEM TO IMPROVE HAEMOSTATIC CONTROL
#364METHOD FOR PRODUCING CENTRE FILLED GUMMIES COMPRISING FILLINGS
#365T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF
#366Near infrared fluorescent dyes, formulations and related methods
#367NāN-dimethyltryptamine (DMT) and DMT analog compositions, methods of making, and methods of use thereof
#368SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS
#369TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS
#370TRANSPORE DELIVERY OF STEROIDS AND LARGE MOLECULES
#371Anti-CD70 antibody drug conjugates
#372Method for stabilization and delivery of therapeutic molecules
#373Postbiotic extract and preparation process and use thereof
#374BIOMARKERS FOR NANOPARTICLE COMPOSITIONS
#375SWELLABLE GELATIN COMPOSITIONS
#376Postbiotic extract and preparation process and use thereof
#377THROMBOSOMES AS AN ANTIPLATELET AGENT REVERSAL AGENT
#378SPIROINDOLONE COMPOSITIONS AND METHODS FOR THE TREATMENT OF MALARIA
#379Pharmaceutical compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione and methods of using the same
#380DUAL TREATMENT OF MIGRAINE
#381COMPOSITIONS AND METHODS OF USING A PLA2-RESPONSIVE DRUG DELIVERY SYSTEM
#382ADHESIVE DRUG CARRIER
#383EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#384PEPTIDE IMMUNOGENS AND FORMULATIONS THEREOF TARGETING MEMBRANE-BOUND IgE FOR TREATMENT OF IgE MEDIATED ALLERGIC DISEASES
#385METHODS OF TREATING SOLID TUMORS USING NANOPARTICLE MTOR INHIBITOR COMBINATION THERAPY
#386PARENTERAL NUTRITION FORMULATION
#387PRODUCTS AND METHODS FOR EXTENDING THE SHELF LIFE OF WATER SENSITIVE PRODUCTS
#388Methods of generating cross-linked protein foams in situ
#389GELATIN PARTICLES, METHOD FOR PRODUCING GELATIN PARTICLES, GELATIN PARTICLE-CONTAINING CELL, AND METHOD FOR PRODUCING GELATIN PARTICLE-CONTAINING CELL
#390DOCK TAG SYSTEM
#391Emulsions and derivatives for infusing hydrophobic active agents into an edible product
#392NOVEL ALPHA-HELICAL DOUBLE-SIDED CELL PENETRATING PEPTIDE AND USE THEREOF
#393Compositions and methods for treating epilepsy, seizures and other conditions
#394DRUG COMPRISING PLGA NANOPARTICLES LOADED WITH CAPE TARGETED WITH ANGIOPEP-2 PEPTIDE
#395FLUID GEL COMPOSITIONS
#396BIODEGRADABLE COMPOSITIONS AND IMPLANTS
#397SELF-ASSEMBLING PEPTIDE
#398Compositions for enhancing bioavailability of pharmaceuticals, supplements and ingested substances
#399LIQUID FORMULATION OF GM-CSF FOR INHALATION
#400SYSTEMS AND METHODS FOR ADMINISTERING HYDRATION COMPOSITIONS
#401HYDRATION COMPOSITIONS
#402USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, AND NICOTINAMIDE MONONUCLEOTIDE, REDUCED NICOTINYL COMPOUNDS, AND NICOTINOYL COMPOUND DERIVATIVES IN INFANT FORMULA FOR HEALTHY DEVELOPMENT
#403Composition of drug targets and method of using thereof
#404VACCINE FORMULATIONS WITH INCREASED STABILITY
#405PURIFIED AMPHIPHILIC PEPTIDE COMPOSITIONS AND USES THEREOF
#406CELL HARVEST METHOD
#407COMPOSITIONS AND METHODS CONTAINING EXOSOMES
#408Methods and compositions for treating cancer
#409PHARMACEUTICAL COMPOSITIONS OF ALBUMIN AND RAPAMYCIN
#410THEAFLAVIN COMPOSITION CAPABLE OF PROMOTING WOUND HEALING AS WELL AS PREPARATION METHOD AND USE THEREOF
#411FORMULATIONS OF DOCETAXEL
#412A TOPICAL ANTIBIOTIC CONTAINING PHARMACEUTICAL COMPOSITION FOR BACTERIAL INFECTIONS AND WOUND HEALING
#413COMPOSITIONS AND METHODS FOR TREATING WOUNDS
#414ADJUVANTED CONJUGATE OPIOID VACCINE
#415SOLID DOSE PHARMACEUTICAL COMPOSITION
#416SARS-COV-2 VACCINE
#417METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE I
#418VIRAL VECTOR STABILIZATION
#419DRUG DELIVERY SYSTEM WITH ENHANCED IMMUNE ACTIVE FUNCTION
#420DERMAL FILLER
#421Wafer-Scale Protein Patterning of Hydrogel Devices
#422CANNABINOID MEDICAL CARRIER
#423METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENTS
#424BEAUTY MICRONEEDLE ARRAY
#425COLLAGEN-BASED DEVICE HAVING ANTIFUNGAL PROPERTIES
#426DOSAGE FORMS OF TAFAMIDIS AND ITS PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#427GELATIN METHACRYLOYL-BASED MICRONEEDLE PATCHES FOR DELIVERY OF WATER-INSOLUBLE DRUGS
#428THERAPEUTIC ARTICLE OF MANUFACTURE WITH NANOPARTICLES TO PROMOTE WOUND HEALING AND/OR ANTIMICROBIAL INFECTION CONTROL
#429NANOPARTICLES TO PROMOTE WOUND HEALING AND ANTIMICROBIAL INFECTION CONTROL
#430N-N-DIMETHYLTRYPTAMINE (DMT) AND DMT ANALOG COMPOSITIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF
#431CHIMERIC RECEPTOR BINDING PROTEINS RESISTANT TO PROTEOLYTIC DEGRADATION
#432EPI-X4 BASED PEPTIDES AND DERIVATIVES THEREOF
#433ANTIBODY-CONJUGATES WITH IMPROVED THERAPEUTIC INDEX FOR TARGETING HER2 TUMOURS AND METHOD FOR IMPROVING THERAPEUTIC INDEX OF ANTIBODY-CONJUGATES
#434FILAMENTOUS NANOSTRUCTURES AND THEIR USE FOR TREATMENT OF PULMONARY DISEASE
#435Artificial beta cells and methods of use thereof
#436PLATELET LYSATE FOAM FOR CELL CULTURE, CELL THERAPY AND TISSULAR REGENERATION AND METHOD FOR OBATINING SAME
#437PUTRESCINE TOPICAL FORMULATIONS
#438PRODUCTS AND METHODS FOR EXTENDING THE SHELF LIFE OF WATER SENSITIVE PRODUCTS
#439Conditions Improving Poxvirus Stability
#440METHODS OF TREATING DIARRHEA OR INFLAMMATORY CONDITIONS OF THE GUT
#441PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
#442CARRIER FOR THE ORAL ABSORPTION OF AN ACTIVE SUBSTANCE BY ANIMALS, METHOD FOR PREPARING SAME AND USES THEREOF
#443SLEEP-INDUCING BEVERAGE COMPOSITION, ITS METHOD OF PRODUCTION AND THE METHOD OF USE
#444METHOD FOR TREATING CHRONIC GRAFT VERSUS HOST DISEASE
#445PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
#446Injectable shear-thinning hydrogel containing therapeutic agent for enhanced tumor therapy
#447ANTI-TUMORAL COMPOUND AND RELATIVE PRODUCTION PROCESS
#4483D PRINTED, FREEZE-DRIED HYDROGELS AND METHODS OF MAKING AND USING THE SAME
#449NANOPARTICLES ENCAPSULATING SMALL MOLECULES
#450PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
#451Methods for increasing growth of beneficial bacteria in the gastrointestinal tract
#452PERIODONTAL MICROPATCH AND USES THEREOF
#453CHEMICALLY CROSS-LINKED HYDROGEL AND ITS MICROSPHERES, PREPARATION METHOD AND APPLICATION
#454MICROBIOME DELIVERY PLATFORM
#455COMPOSITIONS AND FORMULATIONS INCLUDING CABAZITAXEL AND HUMAN SERUM ALBUMIN
#456Collagen-based therapeutic delivery systems
#457EXCIPIENT COMPOUNDS FOR PROTEIN PROCESSING
#458COMPOSITION FOR INTRAPERICARDIAL INJECTION COMPRISING STEM CELLS AND USE THEREOF
#459Formulations of dengue virus vaccine compositions
#460PROTEINS FOR STABILIZATION OF BIOLOGICAL MATERIAL
#461Compositions, methods, and systems for orally administrable affinity-based protein
#462BIOTIN MOIETY-CONJUGATED POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING THE SAME
#463STABLE COMPOSITIONS OF PEGYLATED CARFILZOMIB COMPOUNDS
#464NOVEL CELLULAR DELIVERY METHODS
#465Stable dry powders and emulsions containing probiotics
#466Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
#467PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
#468RESIDENCE STRUCTURES AND RELATED METHODS
#469ANTI-PD-L1 ANTIBODY FORMULATIONS
#470Albumin variants and conjugates
#471OPHTHALMOLOGICAL DEVICE FOR THE TREATMENT OF LSCD AND SUBSTRATE FOR USE IN SAME
#472Method of treating a person afflicted with COVID-19 and pharmaceutical formulation including dapsone
#473PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC POLYSACCHARIDE-CARRIER PROTEIN CONJUGATES
#474Viscosity-reducing excipient compounds for protein formulations
#475EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS
#476Proangiogenic protein cocktails delivered in custom biomaterials to revascularize ischemic tissue
#477Hydrogel composition, hydrogel biomedical material, method for facilitating regeneration of bone and manufacturing method of hydrogel composition
#478SYNTHETIC BIOMARKERS FOR DIFFERENTIAL SEROLOGICAL DIAGNOSIS OF CUTANEOUS LEISHMANIASIS (CL) CAUSED BY VARIOUS LEISHMANIA SPECIES
#479Collagen gel formulations
#480NANOPARTICLE COMPOSITIONS AND METHODS OF USE
#481UV LIGHT-RESPONSIVE HYPERBRANCHED POLY-BETA-AMINO ESTER HAVING HIGH-EFFICIENCY GENE DELIVERY ABILITY AND PREPARATION METHOD AND APPLICATION THEREOF
#482DISPERSION SOLUTION OF COMPLEX OF CERIUM OXIDE NANOPARTICLE WITH PROTEIN, METHOD OF SCAVENGING REACTIVE SPECIES, AND METHOD OF PRODUCING DISPERSION SOLUTION OF COMPLEX OF CERIUM OXIDE NANOPARTICLE WITH PROTEIN
#483SOLID DOSE PHARMACEUTICAL COMPOSITION
#484BIOMARKERS FOR NANOPARTICLE COMPOSITIONS
#485CELL DELIVERY ARTICLES AND METHODS OF ADMINISTRATION
#486PEPTIDE ENCAPSULATING FERRITIN
#487EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
#488MULTIPLE ANTIGEN BINDING MOLECULAR FUSION, PHARMACEUTICAL COMPOSITION, METHOD FOR IDENTIFYING LINEAR EPITOPE, AND METHOD FOR PREPARING MULTIPLE ANTIGEN BINDING MOLECULAR FUSION
#489COMPOSITIONS AND METHODS FOR TREATING EPILEPSY, SEIZURES AND OTHER CONDITIONS
#490Compositions and methods for dental mineralization
#491Compositions and methods for treating epilepsy, seizures and other conditions
#492High Concentration Bispecific Antibody Formulations
#493PREVENTION OF VISIBLE PARTICLE FORMATION IN AQUEOUS PROTEIN SOLUTIONS
#494PROTEIN-BASED BIOMATERIAL WITH VISCOELASTIC BEHAVIOUR, PROCESS FOR OBTAINING IT AND USES THEREOF
#495Platforms, compositions, and methods for therapeutic delivery
#496Compositions and methods for transport across the blood brain barrier
#497COMPOSITIONS AND METHODS COMPRISING SELF-ASSEMBLING PEPTIDE-POLYMER NANOFIBERS FOR SUBLINGUAL IMMUNIZATION
#498USE OF THE GDF-5 MUTANT FOR THE TREATMENT OF PAIN AND CARTILAGE DESTRUCTION
#499PREPARATION OF A THERAPEUTIC COMPOSITION FOR TREATING AUTOIMMUNE DISEASES
#500SORE THROAT REMEDY
#501NUCLEIC ACID DELIVERY ENHANCER
#502Detection of a defect on HLA-E restricted CD8+ T regulatory cells
#503Method for treating type I diabetes with peptide-loaded dendritic cells
#504Method for treating multiple sclerosis with peptide-loaded dendritic cells
#505DELIVERY OF A COOLING AGENT TO THE PHARYNGEAL-ESOPHAGEAL SURFACE
#506SOY PROTEINS FOR PREPARATION OF GELS, FIBERS AND FILMS
#507PH-Responsive Nanoparticles for Treating Cancer
#508SELF-EMULSIFYING CANNABIS EXTRACT
#509DERMAL FILLER
#510Neutral pH compositions of docetaxel and human serum albumin
#511Neutral pH compositions of docetaxel and human serum albumin
#512Compositions and methods for reducing at least one symptom of human allergy to cats
#513Method for stabilization and delivery of therapeutic molecules
#514RENAL TARGETING-TYPE DRUG DELIVERY CARRIER HAVING EXCELLENT BIODEGRABILITY
#515Neutral pH compositions of docetaxel and human serum albumin
#516DIMETHYL FUMARATE PARTICLES AND PHARMACEUTICAL COMPOSITIONS THEREOF
#517Hemoglobin Substitute Mixtures Including Reconstituted Plasma and Platelets and Their Manufacture and Use
#518Multifunctional Nanoparticles For Prevention And Treatment Of Atherosclerosis
#519In vivo bulking agent, injection comprising same, and preparation method therefor
#520TARGETED EXOSOME BASED ON RBD REGION OF SARS-COV-2 S PROTEIN AND PREPARATION METHOD THEREOF
#521Vaccine delivery method
#522NK CELL IMMUNOTHERAPY COMPOSITIONS, METHODS OF MAKING AND METHODS OF USING SAME
#523Compositions, methods of treatment, and containers including compositions
#524Compositions for management of polycystic ovary syndrome
#525LIPOSOMAL CANNABINOIDS AND USES THEREOF
#526ORAL COMPOSITIONS AND METHODS OF MANUFACTURE
#527Emulsions and derivatives for infusing hydrophobic active agents into an edible product
#528SILK FIBROIN-BASED MICRONEEDLES AND USES THEREOF
#529Method and kit for bowel preparation
#530DISCONTINUOUS GUMMY DELIVERY SYSTEMS
#531SILK-DERIVED PROTEIN FOR TREATING INFLAMMATION
#532THERAPEUTIC PEPTIDES
#533Ocular applications of silk-based products
#534METHODS AND COMPOSITIONS COMPRISING STAPHYLOCOCCUS PROTEIN A (SPA) VARIANTS
#535COMPOSITIONS OF EXOSOMES AND AAV
#536Oligodendrocyte-derived Extracellular Vesicles for Therapy of Multiple Sclerosis
#537Methods for Increasing the Bioavailability of OTC and Pharmaceutical Drugs
#538THERAPEUTIC HYDROGELS
#539Method for removing acetaldehyde
#540STABILIZING BUFFER FOR FACTOR VIII AND VWF
#541STABLE COLLOIDAL DRUG AGGREGATES AND METHODS OF MANUFACTURE AND USE THEREOF
#542NON-ORAL MEDICATED CANNABINOID COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT
#543DELAYING PEAK EFFECT AND/OR EXTENDING DURATION OF RESPONSE
#544Modified Interleukin 2 (IL-2) Polypeptides, Conjugates and Uses Thereof
#545CHIKUNGUNYA VACCINE FORMULATIONS
#546Composition comprising EPA, MA and leucine for improving muscle function
#547CO-DELIVERY OF TGF-B siRNA AND PDL1 siRNA TO TREAT CANCER
#548ANTI-TNFR2 ANTIBODIES AND USES THEREOF
#549IMMUNE TOLERANT ELASTIN-LIKE RECOMBINANT PEPTIDES AND METHODS OF USE
#550PHARMACEUTICAL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF
#551Drug delivery composition, method forming the same and method for treating inner ear disorders
#552IMPROVED FORMULATIONS FOR IMMUNE CELLS
#553METHODS OF USING MODIFIED CYTOTOXINS TO TREAT CANCER
#554Composition comprising at least one natural or synthetic non-euphoric cannabinoid and its method of manufacture
#555On Demand Drug Release System
#556ASPARTIC PROTEASE-TRIGGERED ANTIFUNGAL HYDROGELS
#557MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITIONS AND METHODS OF USING THE SAME
#558A RECEPTOR-TARGETING CONJUGATE WITH AN EFFECTIVE PHARMACOKINETIC PROFILE
#559BOTULINUM TOXIN TYPE A COMPLEX, AND FORMULATION THEREOF AND USAGE METHOD THEREFOR
#560COMPOSITIONS COMPRISING BACTERIAL STRAINS
#561HUMAN ANTIBODIES TO BONE MORPHOGENETIC PROTEIN 6
#562Protection and delivery of multiple therapeutic proteins
#563ULTRASOUND-TRIGGERED LIPOSOME PAYLOAD RELEASE
#564Composite Including Neural Retina, Retinal Pigment Epithelial Cells, and Hydrogel, and Method for Producing Same
#565COMPOSITION FOR TREATING OR PREVENTING MILD COGNITIVE IMPAIRMENT
#566Appetite suppressant compositions and methods thereof
#567Surfactant peptide nanostructures and uses thereof in drug delivery
#568Designed Inhibitors of Tight Junction Formation
#569Artificial protein catalyst
#570Formulations of PBMCs
#571COMPOSITION OF PHARMACEUTICAL CARRIER SOLUTION FOR MESENCHYMAL STEM CELLS AND USE OF THE SAME
#572Method for the production of iodinated proteins with a determinated iodine content
#573METHOD AND VEHICLE FOR DELIVERING AGENTS ACROSS THE BLOOD-BRAIN BARRIER
#574CROSSLINKABLE HYDROGEL COMPOSITIONS
#575METHODS FOR TREATING CANCERS WITH MODIFIED PBMCS
#576AN AMNIOTIC FLUID COMPOSITION AND METHOD OF USING
#577CELL LAYER PERMEATION PROMOTER. COMPOSITION FOR FACILITATING DRUG ABSORPTION. AND PHARMACEUTICAL COMPOSITION
#578FORMULATIONS OF FOSAPREPITANT AND APREPITANT
#579Therapeutic pharmaceutical composition for cancer including miRNA
#580MODIFIED COLLAGEN
#581Surgical system and methods of use
#582LIVE ATTENUATED INFLUENZA VACCINE COMPOSITION AND PROCESS FOR PREPARATION THEREOF
#583GEL BASE COMPOSITION FOR COMPOUNDING INTO A MUCOADHESIVE DELIVERY SYSTEM
#584Peptide, compositions and method for delivery of agents into cells and tissues
#585TOPICAL COMPOSITIONS FOR SKIN COMPRISING A CELL PENETRATING PEPTIDE AND METHODS OF USING THE SAME
#586COMPOSITIONS COMPRISING A TWEAK LIGAND AND METHODS OF USING SAME
#587Therapeutic pharmaceutical composition for cancer including miRNA
#588VIRAL FORMULATIONS CONTAINING AMINO ACIDS
#589Compositions for management of acute nephrotoxicity
#590LYOPHILIZED VIRUS FORMULATIONS
#591METHODS OF USING DIPIVEFRIN
#592Compositions for targeting receptor for advanced glycation end-products (RAGE) in a chronic inflammatory condition
#593PRODUCTION OF SALIPRO PARTICLES
#594AMYLOID CONJUGATE AND USES AND METHODS THEREOF
#595LIPID ENCASING AMPHIPATHIC PEPTIDES
#596MIXTURES OF SYNTHETIC COPOLYPEPTIDE HYDROGELS
#597PEPTIDES DERIVED FROM TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY M MEMBER 1 (TRPM1), COMPLEXES COMPRISING SUCH PEPTIDES BOUND TO MHC MOLECULES
#598PEPTIDE AND USE THEREOF
#599Novel Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide Agonist For Treatment Of Glioblastoma
#600HIGH CONCENTRATION CELL PACKAGING AND SHIPPING